2.43 Viloxazine Extended-Release Capsules in Children and Adolescents With ADHD: Final Results of a Long-Term, Phase 3, Open-Label Extension Study

Authors
Category Primary study
JournalJournal of the American Academy of Child and Adolescent Psychiatry
Year 2023
This article has no abstract
Epistemonikos ID: 93295b8486f3eb9a964ac133d3abfed4150727b3
First added on: Jun 13, 2024